| SYRS Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the SYRS market cap history going back to 6/30/2016:
Also see: SYRS Shares Outstanding History and SYRS YTD Return |
SYRS Market Cap History — Syros Pharmaceuticals Capitalization Over Time
As of 10/24/2024 Syros Pharmaceuticals has a market cap of 55.54 million. Investors often follow the SYRS market cap history to compare the size of the company over time.
This page shows SYRS market capitalization trends over time, with 35 market cap datapoints presented, dating back to 6/30/2016.
| SYRS Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SYRS Historical Market Cap: -21.42% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SYRS Stock Price Chart |
| About Syros Pharmaceuticals Inc |
| Syros Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing new treatments for hematologic malignancies. It is advancing Tamibarotene, a selective RARa agonist, in Phase III and Phase II trials for higher-risk myelodysplastic syndrome (HR-MDS) and acute myeloid leukemia (AML), respectively. Other assets include SY-2101 and SY-5609, with the latter being a potent CDK7 inhibitor for which the company is seeking out-licensing opportunities. We show 35 historical shares outstanding datapoints in our SYRS shares outstanding history coverage, used to compute SYRS market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing SYRS market cap history over the course of time is important for investors interested in comparing SYRS's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of SYRS versus a peer is one thing; comparing SYRS market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like SYRS can fluctuate over the course of history. With this page we aim to empower investors researching SYRS by allowing them to research the SYRS market cap history. |
| SYRS Current Stock Quote |
Quotes delayed 20 minutes  Free SYRS Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| SYRS Share Performance |
| Market Cap Peers |
| Syros Pharmaceuticals (SYRS) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
TALK Market Cap History TALS Market Cap History TAOX Market Cap History TARA Market Cap History TARO Market Cap History TARS Market Cap History TBIO Market Cap History TCDA Market Cap History TCMD Market Cap History TCON Market Cap History More Healthcare companies » |
SYRS Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
